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SUMMARY
The prevalence rate ofHuntington disease in County Donegal between 1961
and 1991 showeda decreasefrom4.4 to 1.6per 100,000population. Emigration
and reduction in family size probably account for the progressive decline in
prevalence. Over the same time period in the rest ofEurope, prevalence has
declined only gradually, or has remained static.
INTRODUCTION
Huntington disease, due to an autosomal dominant gene, is characterised by
cognitive dysfunction, psychiatric disturbance and movement disorder. (The
term Huntington disease is now preferred to the possessive Huntington's
disease). The gene has been localised on chromosome 4, and affected patients
have a trinucleotide repeat expansion 1 of their IT15 gene 2. The prevalence of
Huntington disease has been extensively studied in the United Kingdom (Table
1), and is between 4 and 10 per 100,000 3. In Northern Ireland the prevalence rate
is 6.3 per 100,000 4' . There is no prevalence data available for the Republic of
Ireland. County Donegal was historically part ofthe province ofUlster, and, until
the partition of Ireland, had closer population links with Northern Ireland than
with the rest of Ireland6. We have investigated Huntington disease in County
Donegal withthe aims ofascertaining all living and deceased individualswith the
disease, of estimating trends in prevalence rates, and of establishing a genetic
register of affected and 'at risk' individuals to ensure that long term support and
advice is available to families.
METHODS
The index Huntington disease patients were identified using multiple sources of
ascertainment. Early in 1992, a circular was sent to all general practitioners,
neurologists and psychiatrists, in the Republic of Ireland, requesting the name
and address of known Huntington disease patients, living or deceased. Further
contacts with the regional neurologist, regional psychiatrists, and general
practitioners in County Donegal were made in person or by telephone or letter.
The-diagnostic records in the Department of Medical Genetics at the Queen's
University of Belfast, which date from 1967, were examined. These are the
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clinicalrecordsofpatientsattendingthegeneticcounsellingclinics, includingthe
satellite clinic in Altnagelvin hospital, County Londonderry, where patients from
County Donegal may be seen. No genetic counselling service exists in the
Republic ofIreland. In addition, from detailed examination ofthe pedigrees and
by visiting affected patients and relatives in their homes, other affected and 'at
risk' individuals were identified.
Estimates of prevalence rates per 100,000 population were made for 1961,
1971, 1981 and 1991, using the dates of the decennial census in Ireland. The
prevalence rate was estimated using the formula
P = X/Y x 100,000
where X = number of affected living Huntington disease patients,
and Y = the total population (obtained from the Central Statistics Office,
Dublin).
TABLE I
Prevalence ofHuntington disease per 100,000population in County Donegal.
Year Affected Population Prevalence
1926 7* 152508 4.6
1961 5 113842 4.4
1971 3 108344 2.8
1981 2 125112 2.0
1991 2 128117 1.6
* this older figure is most likely an underascertainment
RESULTS
All families ascertained have been domiciled in County Donegal for many
decades. No patients were ascertained who had recently emigrated from other
parts ofIreland or from the United Kingdom. The prevalence rates are shown in
Table 1. Reliable estimates are not available prior to 1955, but for comparison,
a minimum historical estimate is shown for 1926. Twelve cases were identified
over the period 1961-1991. One patient is still alive. For all patients, the.mean
age at onset was 40.7 years with a mean age ofdiagnosis of44.4 years. For the
11 deceased patients, the mean age atdeath was49.8 years. The mean duration
of the disease was 12.3 years.
DISCUSSION
The survey is virtually a total ascertainment of Huntington disease patients in
County Donegai. This was achieved because the area covered is small, personal
contact with medical practitioners was feasible, and thorough primary and
secondaryfamilytracingwaspossible. CategoriesofHuntingtondiseasepatients
liabletounder-ascertainment inlargerpopulation studiessuchasnewmutations,
families with no current affected living members, or affected individuals from
outside the area, are unlikely to have been excluded from this study.
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All the patients appearto have a familial origin in County Donegal foratleastfive
decades, and indeed some families can be traced back to the early 1800's. The
prevalence rate has steadily declined as 'at risk' siblings and children have
emigrated to other parts of Ireland, the United Kingdom or abroad. Several
affected emigrant members have been traced to the United Kingdom 4. County
Donegal is mainly a farming community with no major industries. Over the last
five decades, the population has decreased, mainly due to emigration of
employable membersofthepopulation seekingemploymentoutsidethecounty.
The birth rate also has decreased as younger people move away. The ages of
onset and diagnosis are similar to other published studies 3' . The age of death
is slightly lower. Only one patient with juvenile Huntington disease has been
identified, with an age of onset of 10 years, diagnosis at 14 years, and death at
21 years. Only one patient had an onset over 50 years of age.
TABLE 11
Huntington disease: minimum prevalence per 100,000population in the
British Isles
Area
ENGLAND:
Home Counties
London
Cornwall
Northamptonshire
Northamptonshire
Northamptonshire
Northamptonshire
Carlisle (Cumberland)
N E London/Essex
Bedfordshire
Somerset
Leeds/Yorkshire
East Anglia
SCOTLAND:
Moray Firth
West Scotland
Edinburgh & Lothian
Grampian
WALES:
South Wales
South.-Wales
South Wales
North Wales
IRELAND:
Northern Ireland
Republic of Ireland
(County Donegal)
Reference *
Critchley
Minski, Guttmann
Bickford, Ellison
Pleydell
Pleydell
Reid
Oliver
Brewis
Heathfield
Heathfield, Mackenzie
Glendenning
Stevens
Caro
Lyon
Bolt
Venters
Simpson, Johnston
Harper
Walker
Quarrell
Quarrell
Morrison
Present study
* These studies can be found in detail in references 3, 4, 5, 8, 9.
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Year
1934
1938
1953
1954
1955
1960
1970
1966
1967
1971
1975
1976
1977
1962
1970
1970
1989
1979
1981
1988
1988
1991
1991
Prevalence
0.2 - 1.3
1.8
5.6
4.9
6.0
7.2
6.3
2.8
2.5
7.5
5.5
4.2
9.2
560.0
5.2
6.5
9.9
7.5
7.6
8.5
5.5
6.3
1.6
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The trend for the Huntington disease prevalence rate to decline is likely to
continue. In 1993, onlyonepatientwiththediseasewaslivinginCountyDonegal,
and few 'at risk' patients remain. Population studies in Wales 8over a 30 year
period show a gradual downward trend in the prevalence of Huntington disease.
The downward trend in our survey has been more rapid due to emigration of 'at
risk' patients, and a reduction in size of the families compared to previous
generations.
This study, involving a small area, illustrates how random genetic drift in more
isolated populations has a more extreme effect on the prevalence ofthe disease
than in a larger population area. The very high concentration of Huntington
disease in the Moray Firth area in Scotland 9 shows the opposite effect, with
genetic isolation causing a very high-prevalence rate, (Table 11).
PJM is supported by a Royal College ofPhysicians ofIreland Glaxo Fellowship in Molecular Biology.
We thank all our medical colleagues in County Donegal, and all the Huntington disease families for
their co-operation and help with this study.
REFERENCES
1. Morrison PJ. Trinucleotide repeat repeat repeat. Lancet 1993; 342: 385-386.
2. The Huntington's disease collaborative research group. A novel gene containing a trinucleotide
repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993; 72:
971-983.
3. Harper PS. The epidemiology of Huntington's disease.Hum Genet 1992; 89: 365-376.
4. Morrison PJ. The epidemiology and genetics of Huntington's Disease. The Queen's University
of Belfast, 1993. (MD thesis).
5. Morrison PJ, Johnston WP, Nevin NC. The epidemiology of Huntington disease in Northern
Ireland. JMed Genet 1992; 29: 285.
6. Bardon J. A history of Ulster. Blackstaff Press, 1992.
7. Edwards RD. An atlas of Irish History (2nd Ed). Routledge, London 1981.
8. Quarrell OWJ, Tyler A, Jones MP, Nordin M, Harper PS. Population studies of Huntington's
disease in Wales. Clin Genet 1988; 33:189-195.
9. Lyon R. Huntington's Chorea in the Moray Firth area. Br Med J 1962; i:1301-1306.
© The Ulster Medical Society, 1993.